Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 0904-7172

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 0904-7172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

990685e5 169f 44b9 80cc C2ac4675ff96 00

Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg film-coated tablets in unit dose packaging from Major Pharmaceuticals. The label includes dosage strength, dispensing instructions, Rx only designation, and quantity of 30 tablets. The labeler is Major Pharmaceuticals, Livonia, MI, with NDC 0904-7172-07.*

FDA Label Image

Emtricitabine Structure (Emtricitabine Structure)

Chemical structure of Emtricitabine, one of the active ingredients in Emtricitabine and Tenofovir Disoproxil Fumarate tablets by Major Pharmaceuticals.*

FDA Label Image

Tenofovir Disoproxil Fumarate Structure (Tenofovir Df Structure)

Chemical structure diagram of Emtricitabine and Tenofovir Disoproxil Fumarate, showing atomic connections and molecular arrangement of this antiviral compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.